|Denaro||0,00 x 900|
|Lettera||0,00 x 800|
|Min-Max giorno||93,64 - 94,36|
|Intervallo di 52 settimane||86,70 - 135,89|
|Beta (5 anni mensile)||0,76|
|Rapporto PE (ttm)||25,25|
|Prossima data utili||23 ago 2022|
|Rendimento e dividendo (forward)||2,72 (2,92%)|
|Data ex dividendo||23 giu 2022|
|Stima target 1A||110,88|
Shares of Medtronic rose after the company’s earnings and outlook met expectations.
Following is a list of earnings scheduled for release Nov 22-26, along with previews for select companies. Some investors believe that small-cap stocks will benefit from a strong economy, low valuations, and an unfavourable impact of tax reforms. They will keep an eye out for signs that rising costs, labour shortages amid supply chain disruptions will erode U.S. corporate profits this quarter and in the future. It is worth noting that the U.S. stock market will be closed for the Thanksgiving hol
“Medtronic is well aligned with our 2021 pro-recovery thesis, and we see sustainable 5%+ organic growth driven by the company’s 5% WAMGR and supported by pipeline product launches and tuck-in M&A contributions (Micra AV, EV-ICD, EPIX, RDN, Zeus/Synergy, 780G, InPen, DTM, Interstim Micro, and the soft tisssue robot),” noted Cecilia Furlong, equity analyst at Morgan Stanley.